跳至主要内容
临床试验/CTRI/2021/12/038908
CTRI/2021/12/038908尚未招募2/3 期

Comparative evaluation of efficacy of Haridradigana Yoga Basti with Haridradigana ghana Vati and Metformin in the management of Diabetes Mellitus Type II (Prameha)

Dr Varinder Singh1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年1月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Relief in clinical features associated with Diabetes Mellitus Type II(Prameha)

研究概览

简要总结

Patients will be recruited from inclusion criteria

Objectives will be

1.   Toassess the  efficacy of  HaridradiganaYoga Basti with Haridradigana GhanaVati over objective parameters i.e. Blood sugar  levels (Fasting &Post Prandial),  Urine Sugar  level, HbA1c in Diabetes Mellitus Type II

2.    Toassess the  efficacy of Metformin overobjective parameters i.e.  Bloodsugar  levels (Fasting & PostPrandial),  Urine Sugar  level, HbA1c in Diabetes Mellitus Type II

To compare the  efficacy of Haridradigana Yoga Basti with HaridradiganaGhana Vati and   Metformin over  objective parameters i.e. Blood sugar  levels (Fasting & Post Prandial), UrineSugar  level, HbA1c  in Diabetes Mellitus Type II

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients with either sex having age between 20 -60 years 2.Patients recently diagnosed for uncomplicated NIDDM (type 2 diabetes) and having Fasting blood sugar level ≥126 mg/dl Post meal blood sugar level ≥140 mg/dl 3.HbA1c ≥ 6.57 4.Old cases of type-2 DM not taking any other anti-hypoglycaemic drugs.
  • 5.Diabetic Patients suffering from Controlled Hypertension (Blood Pressure not more than ≥140 mmHg or an average Diastolic Blood Pressure not more than ≥90 mmHg) 6.Patients willing to give informed consent 7.Patient fit for Basti Karma as per the Ayurvedic classics.

排除标准

  • 1.Patients suffering from IDDM (Insulin dependent diabetes mellitus) & patient with Type -2 Diabetes on insulin therapy 2.Patients suffering from Juvenile Diabetes or Gestational diabetes (ICD – 10 criteria 024) 3.DM with complications e.g. Retinopathy, Nephropathy, neuropathy ,previous history of coma 4.Patients suffering from any current acute illness, uncontrolled hypertension.

结局指标

主要结局

Relief in clinical features associated with Diabetes Mellitus Type II(Prameha)

时间窗: 1/2 month(45 days)

次要结局

  • 1 To assess the efficacy of Haridradigana Yoga Basti with Haridradigana Ghana Vati over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II(2 To assess the efficacy of Metformin over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II)

研究者

发起方
Dr Varinder Singh
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验